The PATHWAYS puberty blocker trial is not ‘following the Cass Review’

Image by freepik Patient safety and evidence-based care must be the priority for the NHS regarding medical interventions for children. The PATHWAYS puberty blocker trial is not a prioritisation of…

Continue ReadingThe PATHWAYS puberty blocker trial is not ‘following the Cass Review’

PATHWAYS puberty blocker trial is a return to pre-Cass activism

NHS England has finally released the PATHWAYS puberty blocker trial protocol. The reason it’s almost a year late could reasonably be supposed to be because of the impossibility of the…

Continue ReadingPATHWAYS puberty blocker trial is a return to pre-Cass activism